Rethinking Patient Selection in the Era of Advanced Hybrid Closed-Loop Systems

On September 28th, scientists and clinicians who have been closely involved in the development and launch of Control-IQ® technology for the t:slim X2™ insulin pump discussed patient selection in the era of advanced hybrid closed-loop systems at the EASD 2021 Virtual Conference. This presentation includes best practices for your clinic and recent patient reported outcomes. Time was set aside at the end for a live question and answer session.

Rethinking Patient Selection in the Era of Advanced Hybrid Closed-Loop Systems

Load more comments
Comment by from

* Tandem Diabetes Care will have an exhibit table at each event, but Tandem is not the event organizer and does not have control of the information shared outside of its exhibit space.